Menu
My ProfileInvestment OpportunitiesAbout usInvestorsFAQadd your companyNewsContact us
Categories
GoforIsraelUnicornAIMobilityDeeptechClean TechMed TechFintechCybersecurityAgritechOcean TechFoodtechManufacturingMediaBiotechDataDigital HealthSaaS
Catalyst Investors' Club

Search

NAYA Therapeutics

NAYA Therapeutics

NAYA Therapeutics is a clinical-stage biotech developing next-generation bifunctional antibodies for cancer. Its proprietary plug-and-play platform enhances immune synapse formation for precise tumor killing. With lead programs in HCC and multiple myeloma, NAYA is advancing a differentiated pipeline including NY-303 (GPC3 x NKp46), NY- 500 (PD-1 x VEGF), and NY-338 (CD38 x NKp46), with clinical trials starting in 2025–2026.<...

read more
Country
United States
Website
nayatx.com
Founded
2023
Socials
Source of information: 

https://www.nayatx.com/

Add to My List
Key Executives

Daniel Teper

Founder and CEO

Michael G. King

Executive Vice President

Lyn Falconio

CCO

Industries
Biotech
Med Tech
GoforIsrael
Add Your Company

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.